학술논문

Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial
Document Type
Article
Author
Speich, B.Chammartin, F.Briel, M.Bucher, H.C.Abela, I.A.Braun, D.L.Audigé, A.Günthard, H.F.Trkola, A.Kusejko, K.Hasse, B.Mueller, N.J.Amico, P.Stoeckle, M.P.Eichenberger, A.L.Rauch, A.Schuurmans, M.M.Müller, T.F.Tamm, M.Koller, M.T.Aebi-Popp, I.A.Anagnostopoulos, K.Battegay, A.Bernasconi, M.Braun, E.Bucher, D.L.Calmy, H.C.Cavassini, A.Ciuffi, M.Dollenmaier, A.Egger, G.Elzi, M.Fehr, L.Fellay, J.Furrer, J.Fux, H.Günthard, C.A.Haerry, A.Hirsch, B.Hoffmann, H.H.Hösli, M.Huber, I.Kahlert, M.Keiser, L.Klimkait, O.Kouyos, T.Kovari, R.D.Kusejko, H.Martinez De Tejada, G.Marzolini, B.Metzner, C.Müller, K.J.Nemeth, N.Nicca, J.Paioni, D.Pantaleo, P.Perreau, G.Rauch, M.Speck, P.Stöckle, R.Trkola, P.Wandeler, A.Yerly, G.Amico, P.Axel, A.Aubert, J.D.Banz, V.Sonja, B.Beldi, G.Berger, C.Berishvili, E.Binet, I.Bochud, P.Y.Branca, S.Bucher, H.C.Carrel, T.Catana, E.Chalandon, Y.De Geest, S.De Rougemont, O.Dickenmann, M.Dreifuss, J.L.Duchosal, M.Fehr, T.Ferrari-Lacraz, S.Franscini, N.Garzoni, C.Soccal, P.G.Gaudet, C.Golshayan, D.Goossens, N.Hadaya, K.Halter, J.Heim, D.Hess, C.Hillinger, S.Hirsch, H.Hirt, P.Hofbauer, G.Huynh-Do, U.Immer, F.Koller, M.Laager, M.Laesser, B.Lehmann, R.Leichtle, A.Lovis, C.Manuel, O.Marti, H.P.Martin, P.Y.Martinelli, M.McLin, V.Mellac, K.Merçay, A.Mettler, K.Mueller, N.Müller, A.Müller-Arndt, U.Müllhaupt, B.Nägeli, M.Oldani, G.Pascual, M.Posfay-Barbe, K.Rick, J.Rosselet, A.Rossi, S.Rothlin, S.Ruschitzka, F.Schachtner, T.Schanz, U.Schaub, S.Schnyder, A.Schuurmans, M.Sengstag, T.Simonetta, F.Stampf, S.Steiger, J.Stirniman, G.Stürzinger, U.Van Delden, C.Venetz, J.P.Villard, J.Vionnet, J.Wick, M.Wilhlem, M.Yerly, P.
Source
In: Clinical Infectious Diseases. (Clinical Infectious Diseases, 1 July 2022, 75(1):E585-E593)
Subject
Language
English
ISSN
15376591
10584838